Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/01/030341
CTRI/2021/01/030341
Not yet recruiting
未知

To study the outcome of COVID 19 positive patients who have received Remdesivir or Tocilizumab or their combination during their treatment in a tertiary care hospital.

Seth G S Medical College and KEM Hospital Mumbai0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Seth G S Medical College and KEM Hospital Mumbai
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Seth G S Medical College and KEM Hospital Mumbai

Eligibility Criteria

Inclusion Criteria

  • •1\.Laboratory confirmed COVID 19 adults (Age \> 18 years) admitted in KEM Hospital.
  • •2\.Patients in ICMR group 2B and onwards.
  • •3\.Received any of the following drugs alone or in combination: Remdesivir, Tocilizumab.

Exclusion Criteria

  • •1\. Suspected COVID 19 patients.
  • •2\. Positive patients in category 1A to 2A
  • •3\. Pregnant/Lactating patients.
  • •4\. Mortality within 24 hours of admission.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Co-relation of blood sugar levels prior ,during and post hospitalization in Covid -19 patientsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2021/09/036537MMRS Maharashtra medical research society
Not yet recruiting
Not Applicable
Epidemiological study on patients with COVID-19COVID-19
JPRN-UMIN000050989The Jikei University School of Medicine, Japan2,000
Recruiting
Not Applicable
Prospective observational study of COVID-19 patients in the TOKUSHUKAI GROUPThe purpose of this study is to collect information of the clinical course of patients with COVID-19 treated at Tokushukai hospitals with and without antiviral drugs and to explore the clinical course in the acute phase, the frequency of severe disease, and frequency of post COVID-19 condition by the treatment, after adjusting by patient background including risk factor(s) and symptoms at the time of registration.
JPRN-UMIN000053506Shionogi & Co., Ltd.30,000
Recruiting
Not Applicable
Reserch on patients with COVID-19 at Osaka Saiseikai Nakatsu HospitalCOVID-19
JPRN-UMIN000041102Osaka Saiseikai Nakatsu Hospital1,200
Not yet recruiting
Not Applicable
Disease Profile of Covid-19 in patients admitted at AIIMS, Rishikesh
CTRI/2020/08/027169AIIMS Rishikesh